Skip to main content
Top
Published in: Annals of Hematology 7/2004

01-07-2004 | Case Report

A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis

Authors: Hadewijch De Samblanx, Gregor Verhoef, Pierre Zachée, Peter Vandenberghe

Published in: Annals of Hematology | Issue 7/2004

Login to get access

Abstract

In this article we present the case report of a 67-year-old male with a nephrotic syndrome due to a proliferative glomerulonephritis, associated with an angioimmunoblastic T-cell lymphoma. Diagnosis was made on an axillary lymph node biopsy and showed expanded T-cell areas with multiple blood vessels, small mature lymphocytes, eosinophils, and plasma cells. A kidney biopsy was suggestive for a proliferative glomerulonephritis with intra- and extracapillary proliferation. Hypercellular glomeruli were seen, as well as multiple floride crescents. Interstitial edema and fibrosis were absent. Immunohistochemical reactions were negative; there was some mesangial reaction with IgM in the glomeruli. Treatment with high-dose corticosteroids was initiated, with clinical improvement, and was immediately followed by therapy with cyclophosphamide, hydroxydaunomycin, vincristine, and prednisone (CHOP), which induced complete remission with a follow-up of 1 year. To our knowledge, the association of angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis has only been described twice. It concerned elderly men who developed acute renal failure a couple of months after the diagnosis of an angioimmunoblastic T-cell lymphoma. In both, immunoglobulin-containing dense deposits within glomeruli were observed, which was not the case in our patient, where only some mesangial colorization of the IgM in the glomeruli was seen.
Literature
1.
go back to reference Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet I:1070–1073CrossRef Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet I:1070–1073CrossRef
2.
3.
go back to reference Sallah S, Gagnon GA (1998) Review. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haemaol 99:57–64CrossRef Sallah S, Gagnon GA (1998) Review. Angioimmunoblastic lymphadenopathy with dysproteinemia: emphasis on pathogenesis and treatment. Acta Haemaol 99:57–64CrossRef
4.
go back to reference Stensvold K, Brandtsaeg P, Kvaloy S, Scip M, Lie SO (1984) Imunoblastic lymphadenopathy with early onset in two boys: Immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Hematol 56:417–430 Stensvold K, Brandtsaeg P, Kvaloy S, Scip M, Lie SO (1984) Imunoblastic lymphadenopathy with early onset in two boys: Immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Hematol 56:417–430
5.
go back to reference Duwaji MS, Shemin DG, Medeiros LJ, Esparza AR (1995) Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma. Arch Pathol Lab Med 119:377–380PubMed Duwaji MS, Shemin DG, Medeiros LJ, Esparza AR (1995) Proliferative glomerulonephritis with unusual, organized, cylindrical deposits associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma. Arch Pathol Lab Med 119:377–380PubMed
6.
go back to reference Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed
7.
go back to reference Brown HA, Macon WR, Kurtin PJ, Gibson LE (2001) Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. J Cutan Pathol 28:432–438CrossRefPubMed Brown HA, Macon WR, Kurtin PJ, Gibson LE (2001) Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression. J Cutan Pathol 28:432–438CrossRefPubMed
8.
go back to reference Knecht H (1989) Angioimmunoblastic lymphadenopathy: ten years’ experience and state of current knowledge. Semin Hematol 26:208–215PubMed Knecht H (1989) Angioimmunoblastic lymphadenopathy: ten years’ experience and state of current knowledge. Semin Hematol 26:208–215PubMed
9.
go back to reference Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8PubMed Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8PubMed
11.
go back to reference Tobinia K, Minato K, Ohtsu T, Muhai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M (1988) Clinicopathologic, immunophenotypic, and immunogenotypic analysis of immunoblastic lymphadenopathy like T-cell lymphoma. Blood 72:1000–1006PubMed Tobinia K, Minato K, Ohtsu T, Muhai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M (1988) Clinicopathologic, immunophenotypic, and immunogenotypic analysis of immunoblastic lymphadenopathy like T-cell lymphoma. Blood 72:1000–1006PubMed
12.
go back to reference Yao JL, Cangiarella JF, Cohen JM, Chhieng DC (2001) Fine needle aspiration biopsy of peripheral T-cell lymphomas. A cytologic and immunophenotypic study of 33 cases. Cancer 93:151–159PubMed Yao JL, Cangiarella JF, Cohen JM, Chhieng DC (2001) Fine needle aspiration biopsy of peripheral T-cell lymphomas. A cytologic and immunophenotypic study of 33 cases. Cancer 93:151–159PubMed
13.
go back to reference Schlegelberger B, Zwingers T, Hohenadel K, Henne-Bruns D, Schmitz N, et al. (1996) Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 14:593–599PubMed Schlegelberger B, Zwingers T, Hohenadel K, Henne-Bruns D, Schmitz N, et al. (1996) Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 14:593–599PubMed
14.
go back to reference Sallah AS, Bernard S (1996) Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Ann Hematol 37:295–296CrossRef Sallah AS, Bernard S (1996) Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Ann Hematol 37:295–296CrossRef
15.
go back to reference Okamura H, Misawa T (1998) Succesfull treatment of AILD by local irradiation. ORL J Otorhinolaryngol Relat Spec 60:233–235CrossRefPubMed Okamura H, Misawa T (1998) Succesfull treatment of AILD by local irradiation. ORL J Otorhinolaryngol Relat Spec 60:233–235CrossRefPubMed
16.
go back to reference Sallah S, Wehbir R, Lepera P, et al. (1999) The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia. Br J Haematol 104:163–165CrossRefPubMed Sallah S, Wehbir R, Lepera P, et al. (1999) The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia. Br J Haematol 104:163–165CrossRefPubMed
17.
go back to reference Pautier P, Devidas A, Delmer A (1999) Angioimmunoblastic-like T-cell non Hodgkin’s lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32:545–552PubMed Pautier P, Devidas A, Delmer A (1999) Angioimmunoblastic-like T-cell non Hodgkin’s lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32:545–552PubMed
18.
go back to reference Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164PubMed Da’as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164PubMed
19.
go back to reference Tipping PG, Holdsworth SR (2003) T cells in glomerulonephritis. Springer Semin Immunopathol 24:377–393PubMed Tipping PG, Holdsworth SR (2003) T cells in glomerulonephritis. Springer Semin Immunopathol 24:377–393PubMed
20.
go back to reference Wood WG, Harkins MM Nephropathy in angio-immunoblastic lymphadenopathy. Am J Clin Pathol 71:58–63 Wood WG, Harkins MM Nephropathy in angio-immunoblastic lymphadenopathy. Am J Clin Pathol 71:58–63
Metadata
Title
A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis
Authors
Hadewijch De Samblanx
Gregor Verhoef
Pierre Zachée
Peter Vandenberghe
Publication date
01-07-2004
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 7/2004
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0828-5

Other articles of this Issue 7/2004

Annals of Hematology 7/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine